2000 FEL Fellowship, University of Washington

2000 RES Residency, Johns Hopkins Hospital

1977 PhD Johns Hopkins University

1975 MD Johns Hopkins University

1972 AB Johns Hopkins University

Pathogenesis, treatment, and prevention of sexually transmitted viral infections. The primary focus has been on HSV 2 and HPV as well as an interest in the interaction of these pathogens with HIV. The latter area includes the role of HSV 2 in promoting HIV transmission and the role of HIV in accelerating HPV-associated cancers.  The most recent work has involved immunotherapy of HSV 2 infections.

Clinical Validation of a Test for the Diagnosis of Vaginitis.
Gaydos CA; Beqaj S; Schwebke JR; Lebed J; Smith B; Davis TE; Fife KH; Nyirjesy P; Spurrell T; Furgerson D; Coleman J; Paradis S; Cooper CK; Obstetrics and gynecology 2017 Jul

Human Papillomavirus DNA Detection in Older Women-Implications for Cancer Screening and Prevention.
Ermel AC; Fife KH; The Journal of infectious diseases 2016 Mar 23

Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples.
Magaret AS; Mujugira A; Hughes JP; Lingappa J; Bukusi EA; DeBruyn G; Delany-Moretlwe S; Fife KH; Gray GE; Kapiga S; Karita E; Mugo NR; Rees H; Ronald A; Vwalika B; Were E; Celum C; Wald A; Partners in Prevention HSV/HIV Transmission Study Team.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 Nov 17

Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals.
Fife KH; Mugwanya K; Thomas KK; Baeten JM; Celum C; Bukusi E; de Bruyn G; Mujugira A; Vwalika B; Wald A; Lingappa JR; Partners in Prevention HSV/HIV Transmission Study Team.; The Journal of infectious diseases 2015 Dec 23

Frequency of False Positive Rapid HIV Serologic Tests in African Men and Women Receiving PrEP for HIV Prevention: Implications for Programmatic Roll-Out of Biomedical Interventions.
Ndase P; Celum C; Kidoguchi L; Ronald A; Fife KH; Bukusi E; Donnell D; Baeten JM; Partners PrEP Study Team; PloS one 2015 Apr 17

Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial.
Baeten JM; Donnell D; Mugo NR; Ndase P; Thomas KK; Campbell JD; Wangisi J; Tappero JW; Bukusi EA; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kidoguchi L; Coombs RW; Hendrix C; Marzinke MA; Frenkel L; Haberer JE; Bangsberg D; Celum C; Partners PrEP Study Team; The Lancet. Infectious diseases 2014 Oct 7

Unreported antiretroviral use by HIV-1-infected participants enrolling in a prospective research study.
Kahle EM; Kashuba A; Baeten JM; Fife KH; Celum C; Mujugira A; Essex M; De Bruyn G; Wald A; Donnell D; John-Stewart G; Delany-Moretlwe S; Mugo NR; Farquhar C; Lingappa JR; Partners in Prevention HSVHIV Transmission Study Team; Journal of acquired immune deficiency syndromes (1999) 2014 Feb 1

Bariatric surgery outcomes in HIV-infected subjects: a case series.
Selke H; Norris S; Osterholzer D; Fife KH; DeRose B; Gupta SK; AIDS patient care and STDs 2010 Sep

Herpes simplex virus type 2 infection in young adult women: risk factors for infection and frequency of viral shedding.
Fife KH; Williams JA; Thomas AL; Ofner S; Katz BP; Fortenberry JD; Sexually transmitted diseases 2010 Apr

Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic.
Fife KH; Van Der Pol B; Roth AM; Brand J; Arno JN; Madlem J; Juliar BE; Katz BP; Williams JA; Zimet GD; Fortenberry JD; Sexually transmitted diseases 2009 Nov

Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
Fife KH; Wu JW; Squires KE; Watts DH; Andersen JW; Brown DR; Journal of acquired immune deficiency syndromes (1999) 2009 Jul 1

An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK; HS2100275 STUDY TEAM; Sexually transmitted diseases 2008 Jul

The Centers for Disease Control and Prevention revised recommendations for HIV testing: reactions of women attending community health clinics.
Burrage JW; Zimet GD; Cox DS; Cox AD; Mays RM; Fife RS; Fife KH; The Journal of the Association of Nurses in AIDS Care : JANAC 2008 Jan

Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions.
Fife KH; Meng TC; Ferris DG; Liu P; Antimicrobial agents and chemotherapy 2007 Nov 26

A comparison of one year of episodic or suppressive treatment of recurrent genital herpes with valacyclovir.
Fife KH; Almekinder J; Ofner S; Sexually transmitted diseases 2007 May

Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM; Mayo Clinic proceedings 2006 Oct

Incidence and prevalence of herpes simplex virus infections in adolescent women.
Fife KH; Fortenberry JD; Ofner S; Katz BP; Morrow RA; Orr DP; Sexually transmitted diseases 2006 Jul

Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya.
Wools-Kaloustian K; Kimaiyo S; Diero L; Siika A; Sidle J; Yiannoutsos CT; Musick B; Einterz R; Fife KH; Tierney WM; AIDS (London, England) 2006 Jan 2

American Board of Internal Medicine - Internal Medicine

Sexually Transmitted Diseases, Viral Infections, HIV/AIDS, Infections in Immunocompromised Patients.